Recall D-0729-2026

US Class II Ongoing · initiated 2026-07-16

Recalling firm

Fresenius Kabi USA, LLC, IL

Product

Xylocaine (lidocaine HCl Injection, USP), 1%, 500 mg per 50 mL (10 mg per mL), 25 Multiple-Dose Vials, 50 mL, Rx only, Sterile, Fresenius Kabi, Lake Zurich, IL 60047 NDC Tray: 63323-485-57; NDC Vial: 63323-485-03

Reason for recall

Presence of Particulate Matter: Hair was found in products

← All recalls